OPKO Health (OPK) 10-Q2021 Q1 Quarterly report

Filed: 28 Apr 21, 4:50pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: abuse, Alice, Andy, antidiscrimination, belief, BLA, Black, CFO, chair, contravention, diversity, duty, enrichment, entertainment, Ernst, European, EY, fiduciary, Fishel, Food, greatly, incomplete, increasingly, job, John, joint, Krasno, Labour, Latinx, Lee, magnified, Medel, mednax, Merger, Ministry, misleading, mismanagement, nonlease, Paganelli, PDUFA, Pfinnegar, population, professional, properly, proxy, PSA, purportedly, recombinant, repudiating, requisition, Robert, Roger, rollout, Sammy, Somatrogan, stemming, Steve, susceptibility, target, targeted, underrepresented, uneven, unjust, vaccinated, validated, venture, viral, waste, Welfare, Young, Yu

Removed: absenteeism, accepting, adjusting, affecting, alternate, Analyzer, approach, assigned, assignment, avoid, bore, Canada, cancer, candidate, capacity, CAR, comparative, comprised, contemplated, continuity, covering, deducting, delayed, denied, Detroit, diminished, distancing, divert, effort, emerge, encounter, enforceable, evolved, exchanged, exploit, family, favor, FineTech, flexibility, force, forecast, framework, furloughed, healthy, ill, immune, important, improved, infected, injury, Institute, interference, invalidated, involvement, IP, Israeli, July, leveraging, limiting, manufacture, matured, Merck, mid, mitigate, motion, nationwide, notifying, NYC, offered, operational, ophthalmologic, outbreak, oversight, platform, play, PMA, potency, practice, predicted, prevent, produce, promote, put, quarantine, ratably, referring, remote, rest, returned, reverse, RNA, RNAi, robust, rolapitant, role, RXi, safe, serologic, setting, Shekel, split, Steven, stop, suspend, suspended, TerSera, TESARO, thereunder, title, transitioned, treat, unanticipated, underwriting, unforeseen, variety, varubi, VARUBY, vote, wide, withdraw, work, workforce, write, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated OPK transcripts

OPK similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 906 of the Sarbanes-Oxley Act of 2002, I, Adam Logal, Chief Financial Officer of OPKO Health, Inc. (the “Company”), hereby certify that:

The Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: April 28, 2021			/s/ Adam Logal
			Adam Logal
			Senior Vice President and Chief Financial Officer